2018 Baltic URSI Symposium (URSI) 2018
DOI: 10.23919/ursi.2018.8406694
|View full text |Cite
|
Sign up to set email alerts
|

Hybrid model of radio channels occupancy prediction for dynamic spectrum access

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
2
2
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 4 publications
0
1
0
Order By: Relevance
“…Recently, promising results have been obtained with immunotherapy (monoclonal antibodies, e.g., ipilimumab), target therapy (BRAF inhibitors, e.g., vemurafenib; MEK inhibitors, e.g., cobimetinib), and combined treatments (BRAF inhibitors associated to MEK inhibitors, e.g., vemurafenib + cobimetinib) (Napolitano et al 2018;Schadendorf et al 2018). However, these treatments induce severe toxicity, including neutropenia, thrombocytopenia, fatigue, nausea, vomiting, and neurosensory troubles (Jang and Atkins 2014;Roos et al 2014;Lopatka et al 2018;Voskoboynik and Arkenau 2014). The wide range of antineoplastic treatments Electronic supplementary material The online version of this article (https://doi.org/10.1007/s43450-020-00036-2) contains supplementary material, which is available to authorized users.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, promising results have been obtained with immunotherapy (monoclonal antibodies, e.g., ipilimumab), target therapy (BRAF inhibitors, e.g., vemurafenib; MEK inhibitors, e.g., cobimetinib), and combined treatments (BRAF inhibitors associated to MEK inhibitors, e.g., vemurafenib + cobimetinib) (Napolitano et al 2018;Schadendorf et al 2018). However, these treatments induce severe toxicity, including neutropenia, thrombocytopenia, fatigue, nausea, vomiting, and neurosensory troubles (Jang and Atkins 2014;Roos et al 2014;Lopatka et al 2018;Voskoboynik and Arkenau 2014). The wide range of antineoplastic treatments Electronic supplementary material The online version of this article (https://doi.org/10.1007/s43450-020-00036-2) contains supplementary material, which is available to authorized users.…”
Section: Introductionmentioning
confidence: 99%